Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

NAUTNAUT
8 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in NAUTILUS BIOTECHNOLOGY INC

Qube Research & Technologies Ltd holds 257,346 shares of NAUT (NAUTILUS BIOTECHNOLOGY INC), worth $481,237 as of 2026-Q2. The position was increased (+223.2% shares). NAUT represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$481,237

Current Shares

257,346

Total Value Change

+$389,237

Total Shares Change

+242,318

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
257,346
+223.2%
$481,2370.0%$1.87
39
2026-Q1
Decreased
79,623
-35.3%
$308,9370.0%$2.41
0
2025-Q4
Increased
123,121
+138.3%
$240,0860.0%$1.91
37
2025-Q3
Decreased
51,667
-16.9%
$43,6530.0%$0.80
0
2025-Q2
New
62,138
-
$45,0440.0%$0.69
31
2022-Q1
Exited
0
-100.0%
$00.0%$4.24
0
2021-Q4
Increased
25,166
+67.5%
$130,0000.0%$5.35
33
2021-Q3
New
15,028
-
$92,0000.0%$6.16
30

Other major holders of NAUT: RA CAPITAL MANAGEMENT, L.P., Alyeska Investment Group, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used